v3.26.1
Note 13 - Segments - Schedule of Segment Reporting (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Rental income $ 3,684,044 $ 4,032,429
Fees and other income 88,756 92,755
Total revenue 3,772,800 4,125,184
Rental operating costs 1,544,441 1,612,642
General and administrative 1,673,823 1,661,978
Depreciation and amortization 998,969 1,244,104
Impairment of goodwill and real estate assets 524,373 26,943
Total costs and expenses 4,741,606 4,545,667
Interest and other income, net 5,149 5,149
Net gain (loss) in Conduit Pharmaceuticals marketable securities (see Note 9) 1,985 (176,658)
Gain on sales of real estate, net 172,096 4,453,968
Gain on disposition of assets and liabilities, net 3,416,501  
Income tax (expense) benefit (18,057) 25,409
Total other income (expense), net 1,527,600 2,797,398
Net income 558,794 2,376,915
Less: Income attributable to noncontrolling interests (117,885) (111,563)
Net income attributable to Presidio Property Trust, Inc. stockholders 440,909 2,265,352
Mortgage Notes [Member]    
Interest expense - mortgage notes (2,050,074) (1,510,470)
Operating Segments [Member] | Retail Properties [Member]    
Rental income 93,574 262,878
Fees and other income 0 400
Total revenue 93,574 263,278
Rental operating costs 4,832 100,568
General and administrative 0 0
Depreciation and amortization 22,928 31,689
Impairment of goodwill and real estate assets 0 0
Total costs and expenses 27,760 132,257
Interest and other income, net 0 0
Net gain (loss) in Conduit Pharmaceuticals marketable securities (see Note 9) 0 0
Gain on sales of real estate, net 0 4,213,068
Gain on disposition of assets and liabilities, net 0  
Income tax (expense) benefit 0 0
Total other income (expense), net (43,117) 4,054,971
Net income 22,697 4,185,992
Less: Income attributable to noncontrolling interests 0 0
Net income attributable to Presidio Property Trust, Inc. stockholders 22,697 4,185,992
Operating Segments [Member] | Retail Properties [Member] | Mortgage Notes [Member]    
Interest expense - mortgage notes (43,117) (158,097)
Operating Segments [Member] | Office/Industrial Properties [Member]    
Rental income 2,670,580 2,854,030
Fees and other income 82,800 62,362
Total revenue 2,753,380 2,916,392
Rental operating costs 1,630,837 1,618,365
General and administrative 17,499 16,850
Depreciation and amortization 784,276 999,169
Impairment of goodwill and real estate assets 448,734 0
Total costs and expenses 2,881,346 2,634,384
Interest and other income, net 0 0
Net gain (loss) in Conduit Pharmaceuticals marketable securities (see Note 9) 0 0
Gain on sales of real estate, net 0 0
Gain on disposition of assets and liabilities, net 3,416,501  
Income tax (expense) benefit 0 0
Total other income (expense), net 1,873,418 (891,330)
Net income 1,745,452 (609,322)
Less: Income attributable to noncontrolling interests 2,053 (17,959)
Net income attributable to Presidio Property Trust, Inc. stockholders 1,747,505 (627,281)
Operating Segments [Member] | Office/Industrial Properties [Member] | Mortgage Notes [Member]    
Interest expense - mortgage notes (1,543,083) (891,330)
Operating Segments [Member] | Model Home Properties [Member]    
Rental income 919,890 915,521
Fees and other income 5,534 (1,754)
Total revenue 925,424 913,767
Rental operating costs 48,877 48,157
General and administrative 226,882 229,961
Depreciation and amortization 191,292 212,012
Impairment of goodwill and real estate assets 75,639 26,943
Total costs and expenses 542,690 517,073
Interest and other income, net 9 8
Net gain (loss) in Conduit Pharmaceuticals marketable securities (see Note 9) 0 0
Gain on sales of real estate, net 172,096 240,900
Gain on disposition of assets and liabilities, net 0  
Income tax (expense) benefit (15,657) (22,171)
Total other income (expense), net (306,110) (240,973)
Net income 76,624 155,721
Less: Income attributable to noncontrolling interests (119,938) (93,604)
Net income attributable to Presidio Property Trust, Inc. stockholders (43,314) 62,117
Operating Segments [Member] | Model Home Properties [Member] | Mortgage Notes [Member]    
Interest expense - mortgage notes (462,558) (459,710)
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]    
Rental income 0 0
Fees and other income 422 31,747
Total revenue 422 31,747
Rental operating costs (140,105) (154,448)
General and administrative 1,429,442 1,415,167
Depreciation and amortization 473 1,234
Impairment of goodwill and real estate assets 0 0
Total costs and expenses 1,289,810 1,261,953
Interest and other income, net 5,140 5,141
Net gain (loss) in Conduit Pharmaceuticals marketable securities (see Note 9) 1,985 (176,658)
Gain on sales of real estate, net 0 0
Gain on disposition of assets and liabilities, net 0  
Income tax (expense) benefit (2,400) 47,580
Total other income (expense), net 3,409 (125,270)
Net income (1,285,979) (1,355,476)
Less: Income attributable to noncontrolling interests 0 0
Net income attributable to Presidio Property Trust, Inc. stockholders (1,285,979) (1,355,476)
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] | Mortgage Notes [Member]    
Interest expense - mortgage notes $ (1,316) $ (1,333)